Recent work has highlighted the role of transcription factor MYB in acute myeloid leukemia (AML) and has suggested MYB as a potential drug target for AML and other malignancies associated with deregulated MYB function [1,2,3,4,5]. The gene discussed is MYB; the disease is acute myeloid leukemia.